This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): REX003, REX 003
Description: REX-003 is derived from CD133 bone marrow stem cells, under development by Rexgenero.
Pink Sheet Weekly Trademark Review April 7, 2015
Additional information available to subscribers only: